Invited commentary: Medullary thyroid cancer: The importance of RET testing

Surgery

Volumn 141, Issue 1, 2007, Pages 96-99

  Evans, Douglas B ^a   Shapiro, Suzanne E ^a   Cote, Gilbert J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

CODON; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MULTIPLE ENDOCRINE NEOPLASIA; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; SCREENING TEST; THYROID CANCER; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ALGORITHMS; CARCINOMA, MEDULLARY; DNA MUTATIONAL ANALYSIS; GERM-LINE MUTATION; HUMANS; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33845505283     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2006.08.016     Document Type: Editorial

References (3)

1. Kouvaraki M.A., Shapiro S.E., Perrier N.D., Cote G.J., Gagel R.F., Hoff A.O., et al. RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15 (2005) 531-544
2. Brandi M.L., Gagel R.F., Angeli A., Bilezikian J.P., Beck-Peccoz P., Bordi C., et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86 (2001) 5658-5671
3. GeneTests. Multiple endocrine neoplasia type 2. Available online at: www.genetests.org